» Articles » PMID: 28583623

Pre-treatment MDCT-based Texture Analysis for Therapy Response Prediction in Gastric Cancer: Comparison with Tumour Regression Grade at Final Histology

Abstract

Purpose: An accurate prediction of tumour response to therapy is fundamental in oncology, so as to prompt personalised treatment options if needed. The aim of this study was to investigate the ability of preoperative texture analysis from multi-detector computed tomography (MDCT) in the prediction of the response rate to neo-adjuvant therapy in patients with gastric cancer.

Material And Methods: Thirty-four patients with biopsy-proven gastric cancer were examined by MDCT before neo-adjuvant therapy, and treated with radical surgery after treatment completion. Tumour regression grade (TRG) at final histology was also assessed. Image features from texture analysis were quantified, with and without filters for fine to coarse textures. Patients with TRG 1-3 were considered responders while TRG 4-5 as non- responders. The response rate to neo-adjuvant therapy was assessed both at univariate and multivariate analysis.

Results: Fourteen parameters were significantly different between the two subgroups at univariate analysis; in particular, entropy and compactness (higher in responders) and uniformity (lower in responders). According to our model, the following parameters could identify non-responders at multivariate analysis: entropy (≤6.86 with a logarithm of Odds Ratio - Log OR -: 4.11; p=0.003); range (>158.72; Log OR: 3.67; p=0.010) and root mean square (≤3.71; Log OR: 4.57; p=0.005). Entropy and three-dimensional volume were not significantly correlated (r=0.06; p=0.735).

Conclusion: Pre-treatment texture analysis can potentially provide important information regarding the response rate to neo-adjuvant therapy for gastric cancer, improving risk stratification.

Citing Articles

The Applications of Artificial Intelligence in Digestive System Neoplasms: A Review.

Zhang S, Mu W, Dong D, Wei J, Fang M, Shao L Health Data Sci. 2024; 3:0005.

PMID: 38487199 PMC: 10877701. DOI: 10.34133/hds.0005.


Computed tomography-based radiomics nomogram for predicting therapeutic response to neoadjuvant chemotherapy in locally advanced gastric cancer : A scale for treatment predicting.

Chen W, Zhang W, Chen X, Dong W, Cai Y, Cheng J Clin Transl Oncol. 2024; 26(8):1944-1955.

PMID: 38467894 DOI: 10.1007/s12094-024-03417-4.


The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.

Wei C, He Y, Luo M, Chen G, Nie R, Chen X BMC Cancer. 2023; 23(1):1157.

PMID: 38012547 PMC: 10683194. DOI: 10.1186/s12885-023-11619-2.


Computed tomography texture-based models for predicting KIT exon 11 mutation of gastrointestinal stromal tumors.

Guo C, Zhou H, Chen X, Feng Z Heliyon. 2023; 9(10):e20983.

PMID: 37876490 PMC: 10590931. DOI: 10.1016/j.heliyon.2023.e20983.


Are radiomic spleen features useful for assessing the differentiation status of advanced gastric cancer?.

Lyu D, Liang P, Huang C, Chen X, Cheng M, Zhu B Front Oncol. 2023; 13:1167602.

PMID: 37213311 PMC: 10196477. DOI: 10.3389/fonc.2023.1167602.